DEMETRIUS WASHINGTON: Open Payments
NPI 1508124116 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$855 in 7 payments from 4 companies in 2025. Trend: 2023 $1,012 · 2024 $604 · 2025 $855
Food & beverage: $855
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $431 |
| Edwards Lifesciences Corporation | 1 | $181 |
| Ultragenyx Pharmaceutical Inc. | 1 | $122 |
| Axsome Therapeutics, Inc. | 1 | $121 |
Products named: EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), Dojolvi, Auvelity.
Industry payments across CA — which companies pay providers there.
